Development of a 1-step cell-based assay for cost-effective screening of antiviral drugs for vaccinia virus

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 3, 2009, Pages 350-353

  Jesus, Desyreé M ^a   Santos, Élida S ^a   Schnellrath, Laila C ^a   Damaso, Clarissa R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antiviral assay; Cytopathic viruses; Herpes virus; Plaque reduction; Poxvirus

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; NATURAL PRODUCT; ST 246; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL SUSPENSION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DRUG EFFECT; DRUG RESEARCH; HIGH THROUGHPUT SCREENING; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; VACCINIA VIRUS; VIRUS CELL INTERACTION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; COST-BENEFIT ANALYSIS; CYTOPATHOGENIC EFFECT, VIRAL; DRUG EVALUATION, PRECLINICAL; HAPLORHINI; HUMANS; PLAQUE ASSAY; VACCINIA VIRUS;

EID: 67349161885     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.03.015     Document Type: Article

References (18)

1. Andrighetti-Fröhner C.R., Sincero T.C., da Silva A.C., Savi L.A., Gaido C.M., Bettega J.M., Mancini M., de Almeida M.T., Barbosa R.A., Farias M.R., Barardi C.R., and Simões C.M. Antiviral evaluation of plants from Brazilian Atlantic Tropical Forest. Fitoterapia 76 (2005) 374-378
2. Bailey T.R., Rippin S.R., Opsitnick E., Burns C.J., Pevear D.C., Collett M.S., Rhodes G., Tohan S., Huggins J.W., Baker R.O., Kern E.R., Keith K.A., Dai D., Yang G., Hruby D., and Jordan R. N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: identification of novel Orthopoxvirus egress inhibitors. J. Med. Chem. 50 (2007) 1442-1444
3. Ciustea M., Silverman J.E., Druck Shudofsky A.M., and Ricciardi R.P. Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening. J. Med. Chem. 51 (2008) 6563-6570
4. da Silva A.C., Kratz J.M., Farias F.M., Henriques A.T., Dos Santos J., Leonel R.M., Lerner C., Mothes B., Barardi C.R., and Simões C.M. In vitro antiviral activity of marine sponges collected off Brazilian coast. Biol. Pharm. Bull. 29 (2006) 135-140
5. Damaso C.R., and Moussatché N. Protein synthesis in vaccinia virus-infected cells. I. Effect of hypertonic shock recovery. Arch. Virol. 123 (1992) 295-308
6. Duraffour S., Snoeck R., Krecmerová M., van Den Oord J., De Vos R., Holy A., Crance J.M., Garin D., De Clercq E., and Andrei G. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models. Antimicrob. Agents Chemother. 51 (2007) 4410-4419
7. Fenner F., Henderson D.A., Arita I., Jezek J., and Ladnyi I.D. Smallpox and its eradication (1988), World Health Organization, Geneva
8. Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov. Today 5 (2000) 294-300
9. Jesus D.M., Moussatché N., and Damaso C.R. In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC. Int. J. Antimicrob. Agents 33 (2009) 75-79
10. Liu Y., Donner P.L., Pratt J.K., Jiang W.W., Ng T., Gracias V., Baumeister S., Wiedeman P.E., Traphagen L., Warrior U., Maring C., Kati W.M., Djuric S.W., and Molla A. Identification of halosalicylamide derivatives as a novel class of allosteric inhibitors of HCV NS5B polymerase. Bioorg. Med. Chem. Lett. 18 (2008) 3173-3177
11. Mayer A.M., and Hamann M.T. Marine pharmacology in 2001-2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 140 (2005) 265-286
12. Naithani R., Huma L.C., Holland L.E., Shukla D., McCormick D.L., Mehta R.G., and Moriarty R.M. Antiviral activity of phytochemicals: a comprehensive review. Mini. Rev. Med. Chem. 8 (2008) 1106-1133
13. Pereira H.S., Leão-Ferreira L.R., Moussatché N., Teixeira V.L., Cavalcanti D.N., Costa L.J., Diaz R., and Frugulhetti I.C. Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1). Antiviral. Res. 64 (2004) 69-76
14. Prichard M.N., and Kern E.R. Orthopoxvirus targets for the development of antiviral therapies. Curr. Drug Targets Infect. Disord. 5 (2005) 17-28
15. Reis S.A., Moussatché N., and Damaso C.R. FK506, a secondary metabolite produced by Streptomyces, presents a novel antiviral activity against Orthopoxvirus infection in cell culture. J. Appl. Microbiol. 100 (2006) 1373-1380
16. Souza T.M., Abrantes J.L., de A Epifanio R., Leite Fontes C.F., and Frugulhetti I.C. The alkaloid 4-methylaaptamine isolated from the sponge Aaptos aaptos impairs Herpes simplex virus type 1 penetration and immediate-early protein synthesis. Planta. Med. 73 (2007) 200-205
17. Wendeler M., Lee H.F., Bermingham A., Miller J.T., Chertov O., Bona M.K., Baichoo N.S., Ehteshami M., Beutler J., O'Keefe B.R., Götte M., Kvaratskhelia M., and Le Grice S. Vinylogous ureas as a novel class of inhibitors of reverse transcriptase-associated ribonuclease H activity. ACS Chem. Biol. 3 (2008) 635-644
18. Yang G., Pevear D.C., Davies M.H., Collett M.S., Bailey T., Rippen S., Barone L., Burns C., Rhodes G., Tohan S., Huggins J.W., Baker R.O., Buller R.L., Touchette E., Waller K., Schriewer J., Neyts J., DeClercq E., Jones K., Hruby D., and Jordan R. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J. Virol. 79 (2005) 13139-13149